DGFT Lifts Ban on Export of 24 API and
Formulations thereof
·
Paracetamol
and its Formulations Continue under Restricted List
[DGFT Notification No. 02/2015-2020
dated 6 April 2020]
Effect of this Notification: The
Notification No.
50/2015-20 dated 03.03.2020 is amended
to the extent that the above mentioned APIs and Formulations made from these
APIs are made "Free" for export, with immediate effect.
Subject: - Amendment in Export Policy of APIs and
formulations made from these APIs
S.O. (E) In exercise of powers conferred by Section 3 of the
Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read
with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central
Government hereby makes following amendment in the chapter 29 and 30 of the Schedule
2 of the ITCHS Export Policy amending the Notification No. 50/2015-20 dated 03.03.2020
related to export Policy of APIs and formulations made from these APIs:
|
S.No |
ITC HS Codes |
Description |
Present Policy |
Revised Policy |
|
146B |
29332910 |
Tinidazole |
Restricted |
Free |
|
146C |
29332920 |
Metronidazole |
|
|
|
146D |
29335990 |
Acyclovir |
|
|
|
146E |
29362210 |
VitaminB1 |
||
|
146F |
29362500 |
VitaminB6 |
||
|
146G |
29362610 |
Vitamin B12 |
||
|
146H |
29372300 |
Progesterone |
||
|
146I |
29414000 |
Chloramphenicol |
||
|
146J |
29415000 |
Erythromycin Salts |
||
|
146K |
29419050 |
Neomycin |
||
|
146L |
29419090 |
Clindamycin Salts |
||
|
146M |
29420090 |
Omidazole |
||
|
156A |
30042050 |
Formulations made of Chloramphenicol |
||
|
156B |
30042061 |
Formulations made of Erythromycin Salts |
||
|
156C |
30042095 |
Formulations made of Clindamycin Salt |
||
|
156D |
30043919 |
Formulations made of Progesterone |
||
|
156E |
30045032 |
Formulations made of Vitamin B1 |
||
|
156F |
30045034 |
Formulations made of Vitamin B12 |
||
|
156G |
30045039 |
Formulations made of VitaminB6 |
||
|
156H |
30049015 |
Formulations made of Neomycin |
||
|
156I |
30049021 |
Formulations made of Ornidazole |
||
|
156J |
30049022 |
Formulations made of Metronidazole |
||
|
156K |
30049023 |
Formulations made of Tinidazole |
||
|
156L |
30049099 |
Formulations made of Acyclovir |
(Issued from File No. 01/91/180/24/AM20/EC)